Jakob Karén
Jakob Karén publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer-related Molecular Pathways, HER2/EGFR in Cancer Research and Advanced Breast Cancer Therapies.
- World rank
- #4,371,301 of 7,710,434 ranked researchers
- Rank in Sweden
- #52,238 of 71,437
- Works
- 16
- Citations
- 211
- Citations per work
- 13.2
What does Jakob Karén research?
Jakob Karén's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (26%), Computer Science (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences849.0%
- Medicine849.0%
- Life Sciences425.6%
- Everything else320.7%
- Physical Sciences14.7%
- Computer Science14.7%
- 1Oncology26% of their works
- 2Molecular Biology26% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Physiology5% of their works
- 5Computational Theory and Mathematics5% of their works
- 6Immunology and Allergy5% of their works
Research topics
Which keywords describe Jakob Karén's research?
The keywords of their largest research topics: Breast Cancer, Cancer Therapy, Chemotherapy, Cell Cycle, HER2, p53, Trastuzumab and CDK4/6 Inhibitors.
- Virtual Screening
- Surgical Complications
- Molecular Docking
- Histone Deacetylases
- Cell Adhesion
- CDK4/6 Inhibitors
- Trastuzumab
- Cell Cycle
- Cancer Therapy
- Breast Cancer
- Chemotherapy
- HER2
- p53
- Palbociclib
- HDAC Inhibitors
- Integrins
- Pancreatic Cancer
- VEGF
- endothelial progenitor cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Breast Cancer72 topics
- Cancer Therapy62 topics
- Chemotherapy62 topics
- Cell Cycle41 topic
- HER241 topic
- Trastuzumab41 topic
- p5341 topic
- CDK4/6 Inhibitors31 topic
- Palbociclib31 topic
- Cell Adhesion21 topic
- HDAC Inhibitors21 topic
- Histone Deacetylases21 topic
- Integrins21 topic
- Molecular Docking21 topic
- Pancreatic Cancer21 topic
- Surgical Complications21 topic
- VEGF21 topic
- Virtual Screening21 topic
- endothelial progenitor cells21 topic
Where does Jakob Karén work?
Jakob Karén's main affiliation in the publication record is Pelago Bioscience (Sweden), Sweden.
How many publications and citations does Jakob Karén have?
OpenAlex counts 16 works and 211 citations for Jakob Karén, an h-index of 6, ranking #4,371,301 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jakob Karén. Posts are plain text and can be reported.